AUSTRALIAN PRODUCT RECALL

Albuterex Xtreme, Albutarex Xtreme and Albutarex Femme

Published 6 February 2013

Product

Albuterex Xtreme, Albutarex Xtreme and Albutarex Femme (promoted as a fat loss product) Identifying features description Albuterex Xtreme, Albutarex Xtreme and Albutarex Femme

Why it was recalled

The product was found to contain high levels of caffeine as well as quantities of yohimbine and theophylline, none of which are declared on the label of the product.

Hazard

The ingredients yohimbine and theophylline are prescription only ingredients and the mixture of these three ingredients is considered to pose a significant public health risk to the consumer. Symptoms may range from nausea, sweating, increased heart rate, agitation and tremor, to life-threatening heart rhythms and seizures. Risks can be increased and symptoms can be worsened if other caffeine-containing products, or certain other medicines, herbal products or foods, are also consumed.

Read the official notice ↗

Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.